首页> 外文OA文献 >Re-appraisal of risk classifications for primary gastrointestinal stromal tumors (GISTs) after complete resection: indications for adjuvant therapy

【2h】

Re-appraisal of risk classifications for primary gastrointestinal stromal tumors (GISTs) after complete resection: indications for adjuvant therapy

机译：完全切除后重新评估原发性胃肠体间质肿瘤（GIST）的风险分类：佐剂治疗的适应症

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yoshitomo Yanagimoto; Tsuyoshi Takahashi; Kazuya Muguruma; Takahiro Toyokawa; Hiroshi Kusanagi; Takeshi Omori; Toru Masuzawa; Koji Tanaka; Seiichi Hirota; Toshirou Nishida;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Re-appraisal of risk classifications for primary gastrointestinal stromal tumors (GISTs) after complete resection: indications for adjuvant therapy [J] . Yanagimoto Yoshitomo, Takahashi Tsuyoshi, Muguruma Kazuya, Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association . 2015,第2期

机译：完全切除后重新评估原发性胃肠道间质瘤（GIST）的风险分类：辅助治疗的适应症
2. Adjuvant therapy with imatinib mesylate after resection of primary high-risk gastrointestinal stromal tumors in Japanese patients [J] . KandaT., NishidaT., WadaN., International journal of clinical oncology . 2013,第1期

机译：日本患者原发性高危胃肠道间质瘤切除术后甲磺酸伊马替尼的辅助治疗
3. Adjuvant therapy with imatinib mesylate after resection of primary high-risk gastrointestinal stromal tumors in Japanese patients [J] . Tatsuo Kanda, Toshirou Nishida, Norihito Wada, International Journal of Clinical Oncology . 2013,第1期

机译：日本患者原发性高危胃肠道间质瘤切除术后甲磺酸伊马替尼的辅助治疗
4. International classifications of gastrointestinal stromal tumor: a clue for adjuvant imatinib treatment [C] . Tzen Chin-Yuan International Gastric Cancer Congress . 2011

机译：胃肠道间质瘤的国际分类：佐剂伊马替尼治疗的线索
5. Roles of insulin-like growth factor binding protein-3 in gastrointestinal stromal tumors. [D] . Dupart, Jheri J. 2009

机译：胰岛素样生长因子结合蛋白3在胃肠道间质瘤中的作用。
6. Placebo-Controlled Randomized Trial of Adjuvant Imatinib Mesylate Following the Resection of Localized Primary Gastrointestinal Stromal Tumor (GIST) [O] . Ronald P. DeMatteo, Karla V. Ballman, Cristina R. Antonescu, -1

机译：安慰剂对照佐剂甲磺酸伊马替尼的随机试验下面的本地化的切除原发性胃肠间质瘤（GIsT）
7. PCN78 OST-EFFECTIVENESS ANALYSIS OF ADJUVANT THERAPY WITH IMATINIB MESYLATE IN PATIENTS AFTER RESECTION OF LOCALIZED PRIMARY GASTROINTESTINAL STROMAL TUMOR [O] . Krysanov I, Zorin N, Pyadushkina E, 2010

机译：局部原发性胃肠道基质瘤切除术后甲磺酸伊马替尼辅助治疗的PCN78 OST-疗效分析
8. Report on the Relative Efficacy of Oral Cancer Therapy for Medicare Beneficiaries Versus Currently Covered Therapy: Part 2, Imatinib for Gastrointestinal Stromal Tumors (GIST) [R] . Abernethy, A. P., McCrory, D. C. 2005

机译：关于口服癌疗法对医疗保险受益人与目前报道疗法的相对疗效的报告：第2部分，伊马替尼治疗胃肠道间质瘤（GIsT）

Re-appraisal of risk classifications for primary gastrointestinal stromal tumors (GISTs) after complete resection: indications for adjuvant therapy

著录项

引文网络

相似文献

相关主题

期刊订阅